Live Breaking News & Updates on Treating fields

Stay informed with the latest breaking news from Treating fields on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Treating fields and stay connected to the pulse of your community

Results of Novocure's METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024

Results of Novocure's METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Florida , United-states , Germany , Miami , Chicago , Illinois , Israel , Tokyo , Japan , New-hampshire , American

Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

Novocure today announced 20 presentations on Tumor Treating Fields therapy will be delivered at the American Association for Cancer Research Annual Meeting 2024, to be held April 5 to 10 in San...

Israel , Tokyo , Japan , United-states , New-hampshire , Switzerland , San-diego , California , American , Moshe-giladi , American-association-for-cancer-research , Twitter

Novocure's Electrical Cancer Therapy Shows It Can Treat Tumors in the Brain

Novocure said its “Tumor Treating Fields” met the main goal of a pivotal study enrolling non-small cell lung cancer patients with brain metastases. However, results for the electricty-based treatment fell short of statistical significance on several secondary endpoints.

Jonathan-chang , Treating-fields , Leerink-partners , Weight-loss , Besity , Verweight , Diabetes , Massachusetts , Medical-devices , Obesity , Startups

Novocure: METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

Novocure: METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Miami , Florida , United-states , Israel , Switzerland , New-hampshire , Tokyo , Japan , Minesh-mehta , Dennis-riedl , Ingrid-goldberg , Asaf-danziger

Novocure's Lung Cancer Device Slows Progression to Brain in Trial, Shares Rise

Novocure said on Wednesday that its device met the main goal of a late-stage trial by slowing the progression of cancer to the brain in patients with a type of lung cancer,...

Bengaluru , Karnataka , India , Shounak-dasgupta , Shailesh-kuber , Puyaan-singh , Reuters , Tumor-treating-fields , Treating-fields , Lung-cancer , Ung-carcinoma , Ancer-of-the-lung

Novocure's lung cancer device slows progression to brain in trial, shares rise

(Reuters) -Novocure said on Wednesday that its device met the main goal of a late-stage trial by slowing the progression of cancer to the brain in patients ...

Bengaluru , Karnataka , India , Shailesh-kuber , Puyaan-singh , Shounak-dasgupta , Reuters , Tumor-treating-fields , Treating-fields ,

Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

The METIS trial demonstrated 21.9 months median time to intracranial progression for patients treated with Tumor Treating Fields and supportive care compared to 11.3 months for patients treated with...

Toronto , Ontario , Canada , China , United-states , Chinese , Zai-lab-limited-nasdaq , Zai-lab , Exchange-commission , Zai-lab-forward , Zai-lab-limited

Why Is Novocure Stock Trading Higher On Wednesday? - NovoCure (NASDAQ:NVCR)

Novocure's Phase 3 METIS trial results: TTFields therapy, combined with supportive care, significantly prolongs time to intracranial progression for NSCLC brain metastases patients compared to supportive care alone

Novocure-ltd , Treating-fields , Premarket-approval ,

Novocure: INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO

Novocure: INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , New-hampshire , Israel , Belgium , Leuven , Region-flamande , Barcelona , Comunidad-autonoma-de-cataluna , Spain , Luxembourg , Tokyo , Japan

INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO

ROOT, Switzerland--(BUSINESS WIRE)--Mar 11, 2024--

United-states , Israel , Luxembourg , Switzerland , Belgium , New-hampshire , Leuven , Region-flamande , Tokyo , Japan , Barcelona , Comunidad-autonoma-de-cataluna